Literature DB >> 7632931

Homozygous deletions of p16/MTS1 gene are frequent but mutations are infrequent in childhood T-cell acute lymphoblastic leukemia.

H Ohnishi1, M Kawamura, K Ida, X M Sheng, R Hanada, T Nobori, S Yamamori, Y Hayashi.   

Abstract

Fifty-six primary childhood T-cell acute lymphoblastic leukemia (T-ALL) samples and 17 T-ALL cell lines were examined for mutations and homozygous deletions of the p16/MTS1 gene using polymerase chain reaction single-strand conformation polymorphism and Southern blot analysis. Homozygous deletions were found in 22 primary samples (39%) and in 10 cell lines (59%). In contrast, mutations including small deletions and/or insertions were identified in only 4 primary samples (7%) and in 2 cell lines (12%). Mutations included samples (7%) and in 2 cell lines (12%). Mutations included one nonsense mutation at codon 72, one missense mutation at codon 58, one deletion (29 bp from codon 52-61), one insertion (7 bp into codon 50), and two deletion/insertions (codon 63 and intron 1). Four of the six mutations caused subsequent stop codon and presumably produced truncated p16 protein. Our results suggest that p16 gene alterations are involved in the development of T-ALLs and that the inactivation of the p16 gene occurs mainly through homozygous deletions rather than mutations.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7632931

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

Review 1.  The CDKN2A (p16) gene and human cancer.

Authors:  W D Foulkes; T Y Flanders; P M Pollock; N K Hayward
Journal:  Mol Med       Date:  1997-01       Impact factor: 6.354

2.  Genetic aberrations in childhood acute lymphoblastic leukaemia: application of high-density single nucleotide polymorphism array.

Authors:  Sarina Sulong
Journal:  Malays J Med Sci       Date:  2010-07

3.  Loss of p16/INK4A protein expression in non-Hodgkin's lymphomas is a frequent finding associated with tumor progression.

Authors:  R Villuendas; M Sánchez-Beato; J C Martínez; A I Saez; B Martinez-Delgado; J F García; M S Mateo; L Sanchez-Verde; J Benítez; P Martínez; M A Piris
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

4.  Methylation, a major mechanism of p16/CDKN2 gene inactivation in head and neck squamous carcinoma.

Authors:  A K El-Naggar; S Lai; G Clayman; J K Lee; M A Luna; H Goepfert; J G Batsakis
Journal:  Am J Pathol       Date:  1997-12       Impact factor: 4.307

Review 5.  Illegitimate V(D)J recombination involving nonantigen receptor loci in lymphoid malignancy.

Authors:  Masahiro Onozawa; Peter D Aplan
Journal:  Genes Chromosomes Cancer       Date:  2012-02-15       Impact factor: 5.006

6.  Differential expression of cyclin-dependent kinase 6 in cortical thymocytes and T-cell lymphoblastic lymphoma/leukemia.

Authors:  M Chilosi; C Doglioni; Z Yan; M Lestani; F Menestrina; C Sorio; A Benedetti; F Vinante; G Pizzolo; G Inghirami
Journal:  Am J Pathol       Date:  1998-01       Impact factor: 4.307

7.  Interconnecting molecular pathways in the pathogenesis and drug sensitivity of T-cell acute lymphoblastic leukemia.

Authors:  Takaomi Sanda; Xiaoyu Li; Alejandro Gutierrez; Yebin Ahn; Donna S Neuberg; Jennifer O'Neil; Peter R Strack; Christopher G Winter; Stuart S Winter; Richard S Larson; Harald von Boehmer; A Thomas Look
Journal:  Blood       Date:  2009-12-09       Impact factor: 22.113

8.  Meta-analyses of methylation markers for prostate cancer.

Authors:  Danjie Jiang; Yusheng Shen; Dongjun Dai; Yan Xu; Chunjing Xu; Huangkai Zhu; Tao Huang; Shiwei Duan
Journal:  Tumour Biol       Date:  2014-07-23

9.  Effect of p16 on glucocorticoid response in a B-cell lymphoblast cell line.

Authors:  Sun-Young Kim; Kyung-Yil Lee; Dae-Chul Jeong; Hak-Ki Kim
Journal:  Korean J Pediatr       Date:  2010-07-31

10.  Do novo del(9)(p13) in a childhood T-cell prolymphocytic leukemia as sole abnormality.

Authors:  Abdulsamad Wafa; Abdulmunim Aljapawe; Moneeb Ak Othman; Thomas Liehr; Eyad Alhourani; Walid Al Achkar
Journal:  Exp Hematol Oncol       Date:  2014-11-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.